You are here: Archives / Baldessarini Collection / Curriculum Vitae
Sunday, 23.04.2017

Curriculum Vitae

Ross John Baldessarini

 

 

Born:            September 30, 1937, North Adams, MA 01247

Office:          Mailman Research Center 312, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106

                     Tel (617)-855-3203; Fax (617)-855-3479; e-mail: rjb@mrc309.mclean.org

Home:          49 Nehoiden Road, Waban, MA 02168            59 River Road, East Orleans, MA 02643

                     Tel. (617) 969-1831                                         (PO Box 939); Tel (508) 255-7713

Wife:            Frances Holland 0'Brien Baldessarini, A.B., R.N., M.A.

Children:      Anne Ross (b. 5-7-71)

                     John William (b. 8-21-72)

Education

1959             A.B. (Chemistry, highest honors), magna cum laude Williams College, Williamstown, MA

1963             M.D. (Neuroscience) Johns Hopkins University School of Medicine, Baltimore, MD

1978             M.A. (Honorary) Harvard University, Cambridge, MA

1995             DSc (Honorary) Massachusetts College of Liberal Arts

 

Postgraduate Training

1963–1964   Internship, Internal Medicine III Medical Service, Boston City Hospital, Boston, MA

1964–1966   Postdoctoral Research Fellow, Laboratory of Clinical Science (NIMH), National Institutes of Health, Bethesda, MD

1966–1969   Fellow and Resident, Department of Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD

1967–1968   Resident Clinical Chief, Private Psychiatric Inpatient Service (Henry Phipps Psychiatric Clinic),

                     Johns Hopkins Hospital, Baltimore, MD

1968–1969   Chief Resident Psychiatrist (Henry Phipps Psychiatric Clinic), Johns Hopkins Hospital, Baltimore, MD

1969             Fellow, Neurosciences Research Program of Mass. Institute of Technology, Intensive Study

                     Program, Boulder, Colorado

 

Military Service

1964-1966    U.S. Public Health Service (Lt. Commander, retirement grade: Commander)

1966-1980    U.S. Public Health Service (Reserve)

 

Medical Licensure

1965–           Massachusetts (No. 29098; active)

1965–94          Maryland (No. D00320; inactive)

1965–90          California (Inactive)

2006–           National Provider Identifier (NPI) no.:1487644787

 

Specialty Board Certification

1972             American Board of Psychiatry & Neurology (No. 11769, January)

 

Certification in Clinical Research Ethics

2000–           Partners HealthCare Inc, Boston, MA

 

Controlled Substances Permits

1977–           Massachusetts (MB-015168)

1977–           Federal US-DEA (clinical: AB-5925839; research: PB-0042212, through 1993)

 

Academic Appointments

1969–1972   Assistant Professor of Psychiatry, Harvard Medical School, Boston, MA

1972–1977   Associate Professor of Psychiatry, Harvard Medical School, Boston, MA

1978–           Professor of Psychiatry (tenured), Harvard Medical School, Boston, MA

1983–           Professor of Neuroscience in Psychiatry, Harvard Medical School

 

Institutional  Appointments

1966–1969   Lecturer in Physiology Johns Hopkins School of Medicine. Baltimore, MD

1969             Guest Scientist, Neuropsychopharmacology Lab., Massachusetts Mental Health Center, Boston

1969–1973   Assistant Psychiatrist, Mass. General Hospital, Boston, MA

1969–1977   Chief, Laboratory of Neuropsychopharmacology, Mass. General Hospital, Boston, MA

1970–           Founding Consulting Psychiatrist, Psychopharmacology Clinic, Massachusetts General Hospital

1972             Acting Co-director, Inpatient Psychiatric Service, Massachusetts General Hospital

1973–1975   Associate Psychiatrist, Massachusetts General Hospital, Boston, MA

1975–           Psychiatrist, Massachusetts General Hospital, Boston, Massachusetts

1975–           Psychiatrist, McLean Hospital, Belmont, MA

1977–           Associate Director, Mailman Labs. for Psychiatric Research, McLean Hospital, Belmont, MA

1978–1979   Acting Director, Mailman Laboratories for Psychiatric Research, McLean Hospital

1983–1988   Interim Director, Laboratories for Psychiatric Research, Mailman Research Center

1988–           Director, Laboratories for Psychiatric Research, Mailman Research Center

1988–2004   Founding Director, Bipolar & Psychotic Disorders Program, McLean Hospital

1989–           Co-Director, Psychopharmacology Training Service, McLean Hospital

1994–           Founding Director, International Consortium on Bipolar Disorder Research, McLean Hospital

1995–2003   Director,Grand Rounds program, McLean Hospital

1996–           Senior Consulting Psychiatrist, McLean Hospital & Partners Health Care System

1995–2003   Director, Grand Rounds program, McLean Hospital

1996–           Senior Consulting Psychiatrist, McLean Hospital & Partners Health Care System

1996–           Director, Psychopharmacology Consultation Service, McLean Hospital

1996–           Senior Consulting Psychiatrist, Psychopharmacology Outpatient Clinic, McLean Hospital

1996–2003   Director, Psychopharmacology Training McLean & Massachusetts General Hospitals

2004–           Senior Consulting Psychiatrist, Schizophrenia & Bipolar Disorder Program, McLean Hospital

 

Other Professional Appointments

1965–1966   Lecturer in Neurophysiology, Postgraduate Program, National Institutes of Health, Bethesda, MD

1969–1977   Acting Chief, Psychiatric Research Laboratories, Massachusetts General Hospital (summers)

1970–1975   National Institute of Mental Health Research Career Development Awardee

1975–2001   National Institute of Mental Health Career Scientist Awardee

1976–1977   Acting Deputy Chairman, Department of Psychiatry, Massachusetts General Hospital (summers)

1977–           Fellow, American Psychiatric Association (FAPA)

1978             Robins Visiting Professor of Psychiatry, Washington University, St. Louis, MO

1979             Compton Visiting Professor of Chemistry, Williams College, Williamstown, MA

1979             Visiting Professor of Psychiatry, Duke University

1980             Fellow, American College of Neuropsychopharmacology (FACNP)

1981–1988   Part-time Acting Clinical Director, McLean Hospital

1983–           Johns Hopkins University Scholar

1984             Upjohn Visiting Professor of Psychiatry, New York University, New York, NY

1984–1998   Fellow, American College of Psychiatrists (FACP)

1986–           Founding Course Director: Advanced Clerkship on Psychotic Disorders, Harvard Medical School, Boston (HMS-501-M10B)

1986             Beverley Visiting Professor, Clarke Institute of Psychiatry, University of Toronto

1990             Ascher-Globus Visiting Professor of Psychiatry, Cornell-New York Hospital Medical Center

1990             Hernandez Visiting Professor of Psychiatry, Meharry Medical School, Nashville, TN

1990             Alexander Nies Visiting Scholar, University of Vermont College of Medicine

1992             Visiting Professor of Pharmacology & Psychiatry, University of Trondheim, Norway

1992             Visiting Professor of Psychiatry, Stanford University School of Medicine

1993             Residents' Association Annual Visiting Professor, University of Toronto

1993–           Doctoral thesis supervisor in Physiological Psychology, Northeastern University

1994–           Boots Visiting Professor of Pharmacology, Louisiana State University

1994             Dean’s External Reviewer, Department of Psychiatry, University of Toronto

1997             Sandoz Research Institute Visiting Professor, Columbia Medical Center, New York

1997             Residents' Choice Visiting Professor of Psychiatry, Yale Medical School

1997             Visiting Professor, Karl Menninger School of Psychiatry & Mental Health Sciences, Topeka, KS

1998             First Robert deVito Visiting Professor of Psychiatry, Loyola–Stritch Medical School, Chicago,

1999             Beverley Visiting Professor, Addiction and Mental Health Institute, University of Toronto

2001             Visiting Professor of Psychiatry, Stanford University

2003             Director, Psychopharmacology Training McLean Hospital

2003             Eli Lilly Visiting Professor, University of Iowa

2003             Visiting Professor of Psychiatry, Universities of Brescia, Parma, & Rome, Italy

2003             Distinguished Life Fellow of the American Psychiatric Association (DLFAPA)

2004             Visiting Professor of Psychiatry, Mayo Foundation, Rochester, MN

2004             Visiting Professor of Psychiatry, Dartmouth-Hitchcock Medical Center, Hanover, NH

2005             Weisel-Braceland Visiting Professor, Institute of Living, Hartford, CT, 2005

2006          Visiting Professor of Psychiatry, Pennsylvania State Medical Center, Hershey, PA, 2006

2007             Visiting Professor of Psychiatry, University of Helsinki

 

Selected Committee Responsibilities

1969             Consulting Member, Small Grant Study Section, National Institute of Mental Health

1970–1977   Committee on Psyhchiatry Residency Selection & Training, Massachusetts General Hospital, Boston

1972–1982   Thesis Advisor & Lecturer, Predoctoral Training Program, Department of Pharmacology, Harvard Medical School, Boston, MA

1974–2000   Examiner, American Board of Psychiatry and Neurology

1974–1977   Senior Staff Steering Committee; Committee on Promotions and Appointments, Psychiatry Dept., Massachusetts General Hospital, Boston

1975–1976   Member, Search Committee for the Associate Director for Research of Mass. General Hospital

1975–1976   Ethics Committee, Massachusetts Psychiatric Society

1975–1976   Member, Executive Committee on Research, Massachusetts General Hospital

1975–1976   Chairman, Subcommittee on Review of Research Proposals, Massachusetts General Hospital

1975–1985   Regional Representative, Johns Hopkins University School of Medicine, Admissions Committee

1976             Vice-President & Commissioner, Association for Research in Nervous and Mental Disease (ARNMD)

1976–1977   Task Force on ECT of the American Psychopathological Association

1976–1978   Co-director, Boston Collaborative Program on Biological Research in Schizophrenia

1976–1980   Chairman, Task Force on Tardive Dyskinesia of the American Psychiatric Association

1976–           Committee on Research, McLean Hospital, Belmont, MA

1977–           Associate Director, NIMH Psychobiology Training Program, Harvard Medical School, Boston

1977–           Committees on Residency Selection and Education, McLean Hospital, Belmont, MA

1978–           General Executive Committee, MeLean Hospital, Belmont, MA

1978–1981   Search Committee: Professor of Psychiatry, Childrens Hospital-Harvard Medical School

1978–           Executive Subcommittee on Research, McLean Hospital, Belmont, MA

1978–1979   Committee of Professors, Harvard Medical School. Boston

1978–1985   Executive Committee, Department of Psychiatry, Harvard Medical School

1979–1980   Chairman, Task Force on Long-Term Planning for Research Administration, McLean Hospital

1979–1983   Member, Grant Review Committee on Preclinical Psychopharmacology, NIMH

1979–1989   Ad hoc committee on professorial appointments in psychiatry, Harvard Medical School

1980             Association of American Medical Colleges, Council on Graduate Eedical ducation

1980–1983   Chairman, NIMH Basic Psychopharmacology & Neuropsychology Grant Review Committee

1983–1984   Consulting member, Task Force on Biological Testing, American Psychiatric Association

1980–1985   American Psychiatric Association Commission on Psychiatric Therapies; Leader, Group on Antipsychotic Drug Treatment

1981             Member, American Psychiatric Association visiting committee to the People's Republic of China

1981–1982   Search Committee, Dorn Chair of Neuroscience/Neurology, Harvard Medical School

1981–           Postgraduate Fellowship Review Committee, McLean Hospital

1981             Chairman, Annual Program for Scientific Advisors to the McLean Hospital

1982–1992   Executive Committee, Boston Society of Neurology and Psychiatry

1982–           McLean Hospital Committee of Professors

1984–1985   Program Committee, American Society of Pharmacology & Experimental Therapeutics.

1985–1986   Member, 175th Anniversary Symposium and Program Committee, McLean Hospital

1985–1988   Founding Chairman, Institutional Animal Care and Use Committee, McLean Hospital

1985–1988   Member, Subcommittee of Professors Harvard Medical School, Boston

1985–1990   Member, Task Force on Therapeutics, McLean Hospital

1986–1987   President, Boston Society of Neurology and Psychiatry

1986–1992   Associate Director, Intro. Course: Psychopathology & Psychiatry, Harvard Medical School

1987             Member, Trustees' Committee on Research & Development, Massachusetts General Hospital

1987–           Member, McLean Hospital Postgraduate Fellowship Committee

1987–1988   Member, Audiovisual Committee, McLean Hospital

1987–1990   Member, Committee on Research, Massachusetts General Hospital, Boston

1987–1988   Member, Committee of Professors of Psychiatry, Harvard Medical School

1988–1991   Member, Molecular Neuroscience Planning Committee, McLean Hospital

1988–1990   Member, Selection Committee, Dana Foundation Fellowship Program, Harvard Medical School

1988–2003   Member, Medical Research Advisory Board, The Boston Foundation

1988–           Founding Director, Advanced Clerkship in Psychotic Disorders, Harvard Medical School

1989                 Member, Advisory Board, VAMC Psychiatry Program, Brockton, MA

1989             Member, External Advisory Board: University of Pittsburgh Schizophrenia Center

1992–           Member, Adolf Meyer Research Fellowship Development Committee, Johns Hopkins Hospital

1992–1997   Member, External Advisory Board, NIMH Clinical Research Center, University of Pennsylvania

1994                 Dean’s invited external reviewer, Department of Psychiatry, University of Toronto

1994–           Executive Committee on Patient Care Assessment, McLean Hospital

1994–           Junior Faculty Mentor in Psychiatry, Harvard Medical School

1994–           Member, Pharmacy & Therapeutics Committee, McLean Hospital

1995–           Formulary Committee, McLean Hospital

1995–           Member, Adverse Drug Reaction Team, McLean Hospital

1995–           Consultant in psychopharmacology, US Pharmacopeia, Washington, DC

1995             Chairman, Trustees Task Force on Research, McLean Hospital

1996–           Member, McLean–Massachusetts General Hospital Residency Training Committee

1998–1999   Member, Search Committee for Director of Psychiatry, Partners HealthCare Inc., Boston

1998–1999   Member, Search Committee for Director of Geriatric Psychiatry, Partners HealthCare Inc., Boston

1998–1999   Member, Search Committee for new scientists, Mailman Research Center, McLean Hospital

1988–           Member, Advisory Board on Drug Development, Eli Lilly Research Center, Indianapolis

1998–           Member, Advisory Board on treatment of bipolar disorder, Eli Lilly Corporation, Indianapolis

1998–2003   Co-Director, MGH-McLean Residency seminars program in biomedical psychiatry

1998                    Chairman, International Symposium on Therapeutics and Suicide, Miami, FL

1999–           Founding Scientific Advisor, Child and Adolescent Bipolar Disorder Foundation (CABF), Chicago

1999–           Member, Psychiatry Research Committee, Partners HealthCare Corporation, Boston

2000–           Founding Scientific Advisor, Understanding Manic Depression Foundation, New York

2001–           Founding Scientific Advisor, Juvenile Bipolar Research Foundation, New York

2001–2003   Member, Task Force on Suicide, American Psychiatric Association

2001–           Member, advisory council, Child and Adolescent Bipolar Disorder Foundation (CABF)

2003–2005   Member, Task Force on Antidepressants & Suicide, Amer. College of Neuropsychopharmacology

2003–           Member, Committee on Evaluation of Clinical Training Programs, Harvard Medical School

2004             Founding Director, International Society for CNS Drug Trials & Methods (                                  ISCTM)

2005             Ad hoc committee on professorial appointment, Harvard Medical School

2007–2008   McLean Long-Range Planning Subcommittee on Psychotic Disorders

2007–2008   McLean Long-Range Planning Task Force

2010–           Consulting member, Harvard Medical School and Partners HealthCare Center for Drug Policy

2011–14          Member, Task Force on Antecedents to Adult Bipolar Disorder, International Society for Bipolar                 Disorders.

2012–14          Member, Task Force on Antidepressant Treatment in Bipolar Disorder, International Society for Bipolar Disorders

2013–14          Member, search committee for Associate Professor of Clinical Psychiatric Research, McLean Hospital

2014–           Member, Task Force on Lithium Treatment in Bipolar Disorder, International Society for Bipolar Disorders

 

Editorial Boards

1974–1992   Editorial Board, Neuropharmacology

1975–2010   Editorial Board, Archives of General Psychiatry

1975–1996   Consulting Editor, International Review of Neurobiology

1976–           Editorial Board, Archives Internationales de Pharmacodynamie et de Therapie

1976–1978   Editorial Advisory Board, Harbor Area Somatic Therapy Newsletter

1977–1984   Editorial Board, Psychosomatic Medicine

1977–           Editorial Review Panel, New England Journal of Medicine

1977–           Editorial Review Panel, Psychopharmacology

1977–           Editorial Review Panel, Biochemical Pharmacology

1977–2007   Editorial Advisory Board, Progress in Neuropsychopharmacology & Biological Psychiatry

1978–           Editorial Board, Biological Therapies in Psychiatry, Tucson, AZ

1976–1980   Editorial Board, Weekly Psychiatry Update Series, Biomedia, Inc., Princeton, NJ

1980–           Editorial Board, Directions in Psychiatry, Hatherleigh Press, New York, NY

1981–1988   Associate Editor, American Journal of Psychiatry

1982–           Editorial Board, Journal of Clinical Psychopharmacology

1984–1993   Associate Editor, Journal of Clinical Psychiatry

1985–1992   Editorial Board, McLean Hospital Journal

1986–1992   Editorial Board: Neuropsychopharmacology

1987–           Founding Editorial Board, Journal of the British Association for Psychopharmacology (London)

1988-1989       Editorial consultant, Comprehensive Textbook of Psychiatry, Baltimore:

 

                     Williams & Wilkins

1989–           Founding Editorial Board Member, Journal of Psychopharmacology (London)

1989–           Editorial Board, Progress in Neuropsychopharmacology and Biological Psychiatry

                     1989–1997        Editorial Advisory Board, Human Psychopharmacology, Clinical and Experimental

1990–           Editorial Board, Advances in Neuropsychiatry and Psychopharmacology, Raven Press, New York

1992–           Editorial Board, Current Approaches to the Psychoses, Elsevier-Excerpta Medica, Princeton, NJ

1992             Assoc. Editor, APA Treatment Manual: American Psychiatric Association, Washington, DC

1993–           Editorial Board, CNS Drugs, Auckland, NZ

1994–           Editorial Board, Schizophrenia Research

1994–           Editorial Board, Neuropsychiatry: An International Update

1995–           Editorial Board, American Journal of Therapeutics

1995–           Editorial Advisory Board, Essential Psychopharmacology, Hatherleigh Press, New York

1996–2004   Editorial board, International Review of Neurobiology

1997–           Editorial Board, McLean Hospital Psychiatric Update

1997–           Founding editorial board member, Atlantic Psychopharmacology Quarterly

1998–           Editorial Board, Bipolar Disorders Journal

2004–           Editorial Board, Current Psychiatry Reviews

2006–           Editorial Board, Clinical Schizophrenia and Related Psychoses

2010–           Editorial Board, Brazilian Journal of Psychiatry (Jornal Brasilerio de Psychiatria)

2011–           Editorial Board, World Journal of Pharmacology

2011–           Editorial Board, Clinical Neuropsychiatry (Rome)

2012–           Senior Advisory Board, International Journal of Bipolar Disorders

2012–           Editorial Board, World Journal of Psychiatry

2014             Editorial Board, Clinical Psychopharmacology and Neuroscience

2015–           Editorial Board, Düşünen Adam: Journal of Psychiatry and Neurological Sciences, Turkey

2016–           Editorial Board, World Journal of Pharmacology

 

Memberships

1957–           Theta Delta Chi Fraternity

1958–           Phi Beta Kappa Honor Society

1959–           Nu Sigma Nu Medical Society

1966–1969   Baltimore-Washington Neurological Society

1966–1969   Maryland Psychiatric Society

1966–           American Psychiatric Association

1969–           Staff Associates, Massachusetts General Hospital

1969–1973   Northern New England Psychiatric Society

1969–1975   American Association for the Advancement of Science

1970-1973    American Medical Association: Suffolk County Medical Society & Massachusetts Medical Society

1970–           American Neurochemical Society

1970–           Society for Neuroscience

1970–           International Brain Research Organization

1971–           Psychiatric Research Society

1971–1985   Boston Society for Psychiatry and Neurology (Member, Executive Committee, 1983-85)

1972–           American Society of Pharmacology and Experimental Therapeutics

1973–           Massachusetts Psychiatric Society

1973–           Association for Research in Nervous and Mental Disease (Vice President, 1976)

1973–           American Psychopathological Association

1974–           American College of Neuropsychopharmacology

1975–           Baystate PRSO, Inc.

1976–           American Chemical Society, Division of Medicinal Chemistry

1976–           International Society for Biochemical Pharmacology

1977–           Brain Neurochemicals and Behavior Group of the Society for Neuroscience

1978–1980   Boston Neuroendocrinology Society

1980–1981   Finnish Psychiatric Society (Honorary Corresponding Member)

1981–           Finnish Psychiatric Society (Corresponding Fellow)

1981–           World Federation of Societies of Biological Psychiatry

1983–           American Society for Biological Psychiatry

1985–           Boston Society for Neurology and Psychiatry (Founding Member, Board of Directors)

1986–           Associate, The Behavioral and Brain Sciences Associates, Princeton, NJ

1986­1987     President, Boston Society for Neurology and Psychiatry

1986–1990   Member, Newton South High School Parent-Teacher-Student Association, Newton, MA

1986-            Life Member, Friends of McLean Hospital

1987–1988   Royal Society of Medicine, London (Affiliate Member)

1987–           Neuropharmacology Division, American Society for Pharmacology and Experimental Therapeutics

1988–           International Basal Ganglia Society

1988–           International Brain Research Organization (IBRO)

1989–           Bulfinch Society of Massachusetts General Hospital

1990–           International College of Neuropsychopharmacology (CINP)

1992–           Founding Member, American Society of Clinical Psychopharmacology

1994–           Founder, International Consortium for Bipolar Disorder Research

1997–           Professional Associate, National Alliance for the Mentally Ill (NAMI)

1999–           Member, New England Council for Child and Adolescent Psychiatry

1999–           Founding member, International Society for Bipolar Disorders

2000–           Founding member, Federation of European Neuroscience Societies

2001–           Member, Boston Interuniversity Group for the History of Science & Philosophy

2001–           Founding Fellow, International Society for Affective Disorders

2004–           Founding member, National Foundation for Mental Health

2004–           Founding director, International Society for CNS Clinical Trials and Methods (ICTM)

2005–           Member, American Diabetes Association

 

Awards, Honors

Phi Beta Kappa, Williams College, 1958

Highest honors in Chemistry, A.B. Magna cum Laude, Williams College, 1959

Robson Chemistry Prize, Williams College, 1959

Theta Delta Chi Scholar, 1959-1961

Summer Fellow in Pathology, North Adams Regional Hospital, North Adams, MA, 1960

Fellow, Massachusetts Institute of Technology Neurosciences Research Program Intensive Study Program, 1969

Recipient, National Institute of Mental Health Research Career Development Award, Type II (1-KO2-MH-47370), 1970-1975

Northern New England Psychiatric Association Research Prize: First Honorable Mention, 1971

Diplomate, American Board of Psychiatry and Neurology, 1972 (#11769)

Recipient, National Institute of Mental Health Research Scientist Award (1-KO5­MH-47370), 1975-2000

Daniel Efron Research Prize of the American College of Neuropsychopharmacology (ACNP), 1976

Fellow, American Psychiatric Association (FAPA), 1977-

Honorary Master's Degree, Harvard University, 1978

Fellow, American College of Neuropsychopharmacology (FACNP), 1980-

Blacklin Lecturer, University of Tennessee, Memphis, 1981

Goldwyn Lecturer, University of Massachusetts Medical School, Worcester, 1983

Fellow of the American College of Neuropsychopharmacology (FACNP), 1976

Society of Scholars, Johns Hopkins University, 1983-

Fellow, American College of Psychiatrists (FACP), 1984

Wyeth-Ayerst Research Prize Co-investigator, VIII World Congress of Psychiatry, Athens, 1989

Fellow, International College of Neuropsychopharmacology (FCINP), 1990–

Alexander Nies Visiting Scholar, University of Vermont College of Medicine, 1990

Invited Plenary Lecturer, Third International Congress on Schizophrenia Research, Tucson, AZ, 1991

Invited Plenary Lecturerer, Norwegian Society of Pharmacology, Beito, Norway, January, 1992. 

Member, Gilman Society, Johns Hopkins University, 1992-

Boots Distinguished Neuroscientist Award, Louisiana State University, 1994

Honorary Doctor of Science, North Adams State College, 1995

Third Cleghorn Memorial Lecturer, McMaster Univrsity, Hamilton, Ontario, May, 1995

Janssen Visiting Professor of Psychiatry, University of Miami, January, 1997

Invited Plenary Lecturer: American Society for Clinical Psychopharmacology, Barbados,

            February, 1997

First Outstanding Postgradute Educator Award, New England Educational Institute, Pittsfield,

            MA, June, 1998

Nominee, Harvard Medical School Barger Award for Mentoring, 1998, 2001, 2002

Member, National Council for Johns Hopkins Medicine, 1999–

Member, William Henry Welch Society of Johns Hopkins University, 1999–

Nominee: Research Prize of the American Psychiatric Association, 2000

Plenary Speaker, 100th Anniversary, Ohio Psychiatric Association, Columbus, April, 2000

Nominee: Anna-Monika Foundation Prize for Research on Major Affective Disorders, 2001

Life Fellow, American Psychiatric Association (LFAPA), 2001–

Philip Isenberg Psychiatry Teaching Award, Massachusetts General & McLean Hospitals, 2001

American Society for Information Science & Techology (ISI) Highly Cited Researchers

            recognition, 2002

Distinguished Life Fellow of the American Psychiatric Association (DLFAPA), 2003

Falcone-NARSAD Prize for Research on Bipolar Disorder, October, 2003

Plentary International Lecturer (Lectura Magistralis), Italian Society for Psychopathology

            (SOPSI), Rome, Italy, February, 2004

Research Prize, American Foundation for Suicide Prevention, New York, NY, May, 2004

Invited Lecturer, Japanese Lithium Research Society, Hiroshima, Japan, April, 2004

ISI Most Cited in pharmacology and psychiatry, 2004:

   http://hcr3.isiknowledge.com/author.cgi?&link1=Browse&link2=Results&id=1696

Outstanding Psychiatrist–Advancing the Profession Award, Massachusetts Psychiatric Society,

            May, 2005

Harvard Medical School Excellence in Mentoring Award nominee, February, 2006

Plenary International Lecturer (Lectura Magistralis), Italian Society for Psychopathology

            (SOPSI), Rome, Italy,  February, 2006

Visiting Professor of Psychiatry, Milton Hershey/Pennsylvania State University Medical

            Center, Hershey, PA, November, 2006

Inaugural Member, Outstanding Health Professionals Worldwide, January, 2007

America’s Top Doctors of 2006 Award, American Registry, January 2007

Visiting Professor Québec Psychiatric Association, Montréal, February 2007

Visiting Professor of Psychiatry, University of Helsinki, Finland, March, 2007

Plenary Keynote Lecturer, Finnish Psychiatric Association, March, 2007

Research Medal, Finnish Psychiatric Association, March, 2007

Keynote speaker, American Association of CNS Pharmacists, Boulder, CO, April 2007

American Registry: America’s Top Doctors for 2007

Research Prize: International Symposium on Biological Psychiatry, Thessaloniki, Greece,

            December, 2007

McCurdle Lectureship nominee, Cambridge University, Cambridge, England, 2008

Harvard Medical School Excellence in Mentoring Award runner-up, February, 2006

Chemical Reviews most cited papers of 2007 (Zhang A, Neumeyer JL, Baldessarini RJ. Recent

progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders. Chem Rev 2007; 107; 274–302)

Harvard Medical School Excellence in Mentoring Award runner-up, February, 2010

Finalist, McLean Hospital Cataldo Award for Mentoring, March 2010

Marc H. Hollender Visiting Professorship of Psychiatry, Vanderbilt University, Nashville, TN,

            April 2010

Anne Cataldo Mentoring Award, McLean Hospital, September, 2010.

William Silen Lifetime Mentoring Award, Harvard Medical School, June 2012

James Hegarty Memorial Lecturer, Chambersburg Hospital, Chambersburg, PA, June 2013

Guest editor, special issue of Canadian Journal of Psychiatry, 2014

Sterling Visiting Professor of Pharmacology, Sackler School of Graduate Biomedical Sciences,

            Tufts University, Boston, 2014

 

Consultantships, Editorships and Miscellaneous Positions

1970-77  Consultant for Psychiatric Research, Veterans Administration Hospital, Bedford, MA

1970-77  Committee on Research, Massachusetts General Hospital, Boston

1972-73  Consultant for the Development of Neuropsychopharmacological Research Programs, Departments of Pharmacology and Psychiatry, McMaster University, Hamilton, Ontario

1972-77  Consultant in Psychopharmacology and Residency Education Program, McLean Hospital

1973-00  Consultant in Psychiatry & Psychopharmacology, Westwood Lodge Hospital, Westwood, MA

1973-77  Consultant, Inpatient Service & Pharmacy Committee, Lindemann Mental Health Center, Boston

1974-90  Consultant in CNS Pharmacology, Bio-Research Laboratories, SpA,  Milan, Italy

1974-77  Member of Courtesy Staff, McLean Hospital, Belmont, MA

1974-77  Consultant on design of Mailman Neuroscience Research Center, McLean Hospital

1975-76  Consultant, Arnar-Stone Laboratories, Mt. Prospect, IL

1976-77  Consultant to the American Society of Hospital Pharmacists for the US FDA

1976-77  Consultant, Physicians Continuing Medical Education Radio Network, New York

1978-79  Course Co-Director: Introductory Psychiatry, Harvard Medical School, Boston

1978-79  Consultant to the Federal Circuit Court of Boston (Amicus Curiae Brief: Chayet & Sonnenreich)

1978-      Lecturer, Department of Psychology, Harvard College

1979-84  Consultant, Training Program in Behavioral Neurobiology, Northwestern University, Evanston, IL

1979    Consultant in Psychiatry & Psychopharmacology, Chestnut Lodge Hospital, Rockville, MD

1980-90  Consultant in Neuropharmacology and Psychopharmacology to Sandoz Ltd., Basel, Switzerland

1980-85  Course Director, Biomedical Aspects of Psychiatry, McLean Hospital

1980-86  Consultant to Program in Biology and Industrial Relations, University of Massachusetts

1982-85  Lecturer and Coinvestigator, Graduate Training in Pharmacology, Harvard Medical School

1982-93  Member, Board of Directors, Research Biochemicals, Inc., Natick, MA

1982-   Member, Review Committee for Psychiatry Dept., University of Texas Medical Center, Houston, TX,

1982       Consultant to the Vice President for Medical Affairs, Duke University

1982       Consultant to the Dean, Vanderbilt University School of Medicine

1982       Consultant to the Dean, University of Pennsylvania School of Medicine

1983    Reporting faculty member, Dean's Committee on a proposed reorganization of McLean Hospital

1983    Consultant to Grants Review Program Committee, National Institute of Mental Health, Bethesda, MD

1983       Consultant to the Board of Scientific Counsellors, National Institute of Mental Health

1984       Consultant, Carrier Clinic, Princeton, NJ

1984       Consultant in Neuropharmacology, Squibb Pharmaceuticals Corp., Princeton, NJ

1984       Consultant to Friends and Families of Schizophrenia, Honolulu, Hawaii

1984    Consulting Member, NIH Consensus Conference on Treatment of Mood Disorders, Bethesda, MD

1984       Consultant to the Department of Mental Health, Commonwealth of Massachusetts.

1984-86  Consultant on CNS pharmacology, Upjohn Pharmaceuticals Co., Kalamazoo, MI

1984       Consultant to the Dean, University of North Carolina School of Medicine, Chapel Hill

1985-      Member, American Red Cross of Massachusetts Bay

1985       Consultant to the Dean, Yale School of Medicine

1985-90  Consultant in CNS Pharmacology, Sandoz Laboratories, Basel, Switzerland

1985-      Consultant in CNS Pharmacology, Wander Research Institute, Berne, Switzerland

1985-   Consultant, Division of Drugs and Technology, American Medical Association, Chicago, IL

1986-88  Consultant to the Psychiatric Times and Postgraduate Education Corporation, Santa Ana, CA

1986-90  Associate of the Smithsonian Institution, Washington DC

1986    Director: Postgraduate Course in Clinical Psychopharmacology, Psychiatric Institute, Washington, DC.

1986-88   Consultant: American Psychiatric Association Task Force on Treatment of Psychiatric Disorders

1986-90  Founding Course Co-Director: Introduction to Clinical Psychiatry (No. 700), Harvard Medical School

1986-90  Consultant: Pain Program Project, Massachusetts General Hospital, Boston MA

1987-90  Member, Massachusetts Society for Prevention of Cruelty to Animals (MSPCA)

1987-   Consultant to the Massachusetts Mental Health Center Commonwealth Research Center

1987-88  Consultant in CNS Pharmacology, Bristol-Myers Research Division, Wallingford, CT

1987       Consultant to the Department of Mental Health, State of Colorado

1987-90  Consultant in Psychopharmacology, New York Department of Mental Health, Albany, NY

1987-90  Consultant in Neuropharmacology,  Stuart-ICI-Americas Pharmaceuticals Inc., Wilmington, DL

1988       Consultant to Jonathan Livingston Foundation Fellowship Program, Boston

1988    Thesis Advisor: Department of Epidemiology, Harvard School of Public Health, Boston

1988-      Member, Editorial Panel, Journal of Neuropsychiatry and Clinical Neurosciences

1988-95  Thesis advisor, School of Pharmacy, Northeastern University, Boston

1988-89  Consultant, Marion Laboratories, Kansas City, MO

1988-90  Consultant in Neuropharmacology, CNS Research Corporation, Cambridge, MA

1989-      Member, External Advisory Board, VAMC Schizophrenia Center, Yale University

1989-   Member, Neuropharmacology Division, American Soc.  Pharmacology & Exptl Therapeutics

1989-      Consultant in Psychopharmacology, U.S. Veterans Administration

1990-      Consultant to Marion-Merrell-Dow Laboratories, Kansas City, MO

1991-   Consulting Member, Canadian Association for Psychiatric Research Research Prize Committee

1992    Consultant to Task Force on Psychiatric Treatment, American Psychiatric Association, Washington

1993–94 Consultant in psychopharmacology, Pfizer Central Research, Groton, CT

1993–94 Member, Scientific Advisory Board, Research Biochemicals Incorporated (RBI), Natick, MA

1993-94  Consultant, Westat Corporation, Rockville, MD

1993-98  Consultant, Neuromedica, Inc., Cambridge, MA

1993-94  Scientific Advisor, Neuromedica, Inc., Cambridge, MA

1994-      Selectee, American Men and Women of Science

1995-97  Member, Committee on Carreer Development in Psychiatry, Harvard Medical School

1995       Consultant, Chinman-Hoenig Medical-Psychiatric Associates, Wayland, MA

1995       Consultant, Medical Research International AG, Burlington, MA

1995       Consultant on psychotic disorders, Menninger Clinic, Topeka, KS

1995    Consultant on psychotic disorders, McMaster University College of Medicine, Hamilton, Ontario

1996–  Member, Massachusetts Department of Mental Health Practice Guidelines Review Panel

1996       Consultant to the Board of Directors, The Medical Foundation (TMF) of Boston

1997       Consultant to the US VA Psychiatry Department on treatment of bipolar disorders

1997       Consultant in Psychopharmacology to Janssen Foundation

1997–     Consultant in Psychopharmacology to Eli Lilly Laboratories

1997–     Consultant in pharmacology and CNS drug development, Copley Pharmaceuticals

1997–     Consultant in neuropharmacology to Hoechst Pharmaceuticals

1998–     Consultant in psychopharmacology, Eli Lilly Company

1998-03  Consultant, Neuromedica, Inc., Conshohocken, PA

1998–     Consultant in Neuropharmacology, Robert Wood Johnson Research Institute

1999–  Founding International Advisor, Canadian National Consortium for Bipolar Disorders Research

2001–     Consultant, Glaxo-SmithKline Corporation

2001–     Consultant on antipsychotic drug development, Solvay Corporation

2001–     Director, International Collaborative Study: olanzapine treatment for mania, Eli Lilly Research

2001–     Consultant, IFI Pharmaceuticals SpA, Rome, Italy

2002–03 Consultant, Alkermes Corporation, Cambridge, MA

2002–     Consultant, Janssen Pharmaceuticals Inc., Titusville, NJ

2002–     Consultant, Auritec Laboratories, Los Angeles, CA

2002–     Consultant, Johnson & Johnson Corporation, NJ

2002–     Consultant, Unihart Biotech Pharma NV, Amsterdam, Netherlands

2003-      Consultant, JDS Pharmaceuticals, New York, NY

2004       Consultant, special task force on olanzapine risks vs. benefits, Eli Lilly & Co.

2005       Consultant, special task force on suicidal risks of antidepresssants, Eli Lilly & Co.

2005–     Consultant, Novartis Pharmaceutical Corporation, East Hanover, NJ

2006–     Consultant, BioTherapeutix LLC, Waltham, MA

2006–     Consultant, Merck Laboratories, Rahway, NJ

2007–     Director, Newton-Wellesley-Weston Program for Community Living, Newton, MA

2010       Consultant, Alkermes Corporation, Waltham, MA

2010       Consultant, Johnson & Johnson Corporation, New Brunswick, NJ

2012–     Consultant, College of Pharmacy, University of Colorado, Denver, CO

 

 

Ross J. Baldessarini

May 19, 2016